ANF and β-MHC, common biomarkers of cardiac hypertrophy, have been used to investigate hypertrophic effects in clinical studies and animal experiments (Liu et al., 2018; Fulgencio-Covián et al., 2020). Here, NPPA is linked to cardiac hypertrophy.